Acute Aggressive Posterior Progressive Necrotising Retinitis: Re-Evaluating Progressive Outer Retinal Necrosis [0.03%]
急性后极性进行性坏死性视网膜炎：对进行性外层视网膜坏死的再评价
Akshita Aggarwal,Spoorti Mandadi,Avinash Pathengay et al.
Akshita Aggarwal et al.
Purpose: The aim of this paper is to describe and analyse the retinal involvement and Optical Coherence Tomography (OCT) findings in Progressive Outer Retinal Necrosis (PORN) and revisiting its terminology. ...
Comparative Outcomes of Teprotumumab and Tocilizumab in Thyroid Eye Disease: The First Retrospective Study from the United Arab Emirates and Gulf Region of the Middle East [0.03%]
关于甲状腺相关性眼病泰普苏玛布与托珠单抗的疗效比较：来自中东阿拉伯联合酋长国及海湾地区的首个回顾性研究
Habibullah Eatamadi
Habibullah Eatamadi
Methods: A retrospective analysis of 44 TED patients (22 teprotumumab, 2023-2025 at Sheikh Shakhbout Medical City and 22 tocilizumab, 2018-2024 at Sheikh Khalifa Medical City) was conducted. Outcomes included proptosis re...
Distinguishing Fungal Keratitis from HSV Endothelial Keratitis: A Comparative Clinical and Diagnostic Analysis [0.03%]
真菌性角膜炎与HSV内皮角膜炎的临床及诊断鉴别分析
Poornima Tandra,Bhupesh Bagga
Poornima Tandra
Purpose: To differentiate the clinical features of fungal keratitis with predominantly deep stromal and endothelial (FSKE) involvement and HSV Endothelial Keratitis (HEK). ...
Lacrimal History - Part 86: Doyens of Dacryology Series - Georges-P. Robert and His 1899 Thesis on the Actinomycosis of the Lacrimal Ducts [0.03%]
泪史第八十六篇：干眼泰斗系列之乔治-罗贝尔及其1899年关于泪管放线菌病的博士论文
Mohammad Javed Ali
Mohammad Javed Ali
Lacrimal History - Part 84: Doyens of Dacryology Series - Benedict Duddell (1695-1765) and His Controversial Treatise of 1729 [0.03%]
泪器历史：泪器学权威系列(八十四)本杰明·达德利(1695-1765)及其颇具争议的《流泪治疗论》(1729年)
Mohammad Javed Ali
Mohammad Javed Ali
Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial [0.03%]
六 versus 九个月抗结核治疗对眼底脉络膜结核随机对照多中心研究
Talluri Ronnie Abhishek,Md Hasnat Ali,May Zun Aung Win et al.
Talluri Ronnie Abhishek et al.
Purpose: The benefits of anti-tubercular therapy (ATT) in treating ocular tuberculosis (TB) are well documented. However, the optimal duration of ATT remains uncertain. We assessed the efficacy of 6-month ATT compared to ...